Clinical Trials in China / NCT05996016
Recruiting
Observational
Gut and Vaginal Microbiota Profile Study for HIV Women
NCT05996016 · tracked via the Priya Life Science China tracker
Condition(s) studied
HPVHIV InfectionsVaginal Microbiota
Study summary
Women Living with HIV Infection （WLHIV）are intended to acquire HPV infection which usually contributes to variable cervical lesions. we hypothesize that vaginal microbiota imbalance may make WLHIV prone to HPV infection，thereafter results in severe cervical lesion.
Eligibility
Inclusion Criteria:
* HIV women （including pregnant）;
* sign consent paper
Exclusion Criteria:
* virgin or maiden
Primary outcome measure(s)
- HPV infection incidence — 0, 6m, 12m, 24m, 36m
To collect 400 analyzable samples from women with HIV, including HPV screening, fecal and vaginal microflora samples. Cervical HPV screening will be collected as required in standard containers and stored for transport to the central laboratory.the rates of HPV infection. - cervical lesions — 0, 6m, 12m, 24m, 36m
To collect 400 analyzable samples from women with HIV, including vaginal cleanliness assessment and TCT examination. vaginal swab samples will be collected as required in standard containers and stored for transport to the central laboratory.Variable cervical lesions, including CIN I-III and neoplasma.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Peking Union Medical College Hospital | Beijing | Beijing Municipality | Recruiting |
More Peking Union Medical College Hospital trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05996016 on ClinicalTrials.gov ↗ ← All trials in China